首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer
Authors:Jae Young Jang  Hoon Jai Chun  Division of Gastroenterology
Affiliation:Jae Young Jang;Hoon Jai Chun;Division of Gastroenterology,Department of Internal Medicine,College of Medicine,Kyung Hee University,Seoul 136-705,South Korea;Division of Gastroenterology and Hepatology,Department of Internal Medicine,Institute of Digestive Disease and Nutrition,Korea University College of Medicine,Seoul 136-705,South Korea;
Abstract:Helicobacter pylori (H. pylori) plays an important role in gastric carcinogenesis, as the majority of gastric cancers develop from H. pylori-infected gastric mucosa. The rate of early gastric cancer diagnosis has increased in Japan and Korea, where H. pylori infection and gastric cancer are highly prevalent. Early intestinal-type gastric cancer without concomitant lymph node metastasis is usually treated by endoscopic resection. Secondary metachronous gastric cancers often develop because atrophic mucosa left untreated after endoscopic treatment confers a high risk of gastric cancer. The efficacy of H. pylori eradication for the prevention of metachronous gastric cancer remains controversial. However, in patients who undergo endoscopic resection of early gastric cancer, H. pylori eradication is recommended to suppress or delay metachronous gastric cancer. Careful and regularly scheduled endoscopy should be performed to detect minute metachronous gastric cancer after endoscopic resection.
Keywords:Helicobacter pylori   Gastric cancer   Endoscopic resection   Metachronous cancer
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号